Literature DB >> 35110688

Adolescents are more sensitive than adults to acute behavioral and cognitive effects of THC.

Conor H Murray1, Zhengyi Huang1, Royce Lee1, Harriet de Wit2.   

Abstract

Increased cannabis availability has contributed to increased use with concomitant incidence of adverse effects. One risk factor for adverse drug reactions may be age. There is preclinical evidence that acute effects of delta-9-tetrahydrocannabinol (THC), the primary active constituent of cannabis, are greater during adolescence, but this has not been fully studied in humans. The present study sought to determine whether adolescent men and women are more sensitive than adults to acute THC. Adolescents aged 18-20 (N = 12) and adults aged 30-40 (N = 12), with less than 20 total lifetime uses of THC-containing products, received capsules of THC (7.5, 15 mg) and placebo across three study sessions in randomized order under double blind conditions. During each session, subjective, cardiovascular, behavioral, and EEG measures were obtained. Behavioral measures included Simple Reaction Time, Stop Task, Time Production and N-back and EEG measures included P300 amplitudes during an auditory oddball task and eyes-closed resting state. THC affected subjective state and heart rate similarly in both age groups. However, adolescents were more sensitive to performance impairing effects, exhibiting dose-dependent impairments on reaction time, response accuracy, and time perception. On EEG measures, THC dose-dependently decreased P300 amplitude in adolescents but not adults. Adolescents were more sensitive to behavioral and cognitive effects of THC, but not to cardiovascular effects or subjective measures. Thus, at doses that produce comparable ratings of intoxication, adolescents may exhibit greater cognitive impairment and alterations in brain function.
© 2022. The Author(s), under exclusive licence to American College of Neuropsychopharmacology.

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 35110688      PMCID: PMC9117219          DOI: 10.1038/s41386-022-01281-w

Source DB:  PubMed          Journal:  Neuropsychopharmacology        ISSN: 0893-133X            Impact factor:   8.294


  66 in total

1.  The validity of d prime as a working memory index: results from the "Bergen n-back task".

Authors:  Beathe C Haatveit; Kjetil Sundet; Kenneth Hugdahl; Torill Ueland; Ingrid Melle; Ole A Andreassen
Journal:  J Clin Exp Neuropsychol       Date:  2010-04-09       Impact factor: 2.475

2.  Effects of marijuana on neurophysiological signals of working and episodic memory.

Authors:  Aaron B Ilan; Michael E Smith; Alan Gevins
Journal:  Psychopharmacology (Berl)       Date:  2004-05-07       Impact factor: 4.530

3.  Regional enhancement of cannabinoid CB₁ receptor desensitization in female adolescent rats following repeated Delta-tetrahydrocannabinol exposure.

Authors:  James J Burston; Jenny L Wiley; Abimbola A Craig; Dana E Selley; Laura J Sim-Selley
Journal:  Br J Pharmacol       Date:  2010-09       Impact factor: 8.739

Review 4.  Cannabis effects on driving skills.

Authors:  Rebecca L Hartman; Marilyn A Huestis
Journal:  Clin Chem       Date:  2012-12-07       Impact factor: 8.327

5.  Acute effects of THC on time perception in frequent and infrequent cannabis users.

Authors:  R Andrew Sewell; Ashley Schnakenberg; Jacqueline Elander; Rajiv Radhakrishnan; Ashley Williams; Patrick D Skosnik; Brian Pittman; Mohini Ranganathan; D Cyril D'Souza
Journal:  Psychopharmacology (Berl)       Date:  2012-11-24       Impact factor: 4.530

6.  Serotonin receptor expression in human prefrontal cortex: balancing excitation and inhibition across postnatal development.

Authors:  Evelyn K Lambe; Stu G Fillman; Maree J Webster; Cynthia Shannon Weickert
Journal:  PLoS One       Date:  2011-07-29       Impact factor: 3.240

7.  Are adolescents more vulnerable to the harmful effects of cannabis than adults? A placebo-controlled study in human males.

Authors:  C Mokrysz; T P Freeman; S Korkki; K Griffiths; H V Curran
Journal:  Transl Psychiatry       Date:  2016-11-29       Impact factor: 6.222

8.  Sensitivity, Specificity and Accuracy of a Novel EEG-Based Objective Test, the Cognalyzer®, in Detecting Cannabis Psychoactive Effects.

Authors:  Alison C McDonald; Israel Gasperin Haaz; Weikai Qi; David C Crowley; Najla Guthrie; Malkanthi Evans; Dan Bosnyak
Journal:  Adv Ther       Date:  2021-04-07       Impact factor: 3.845

Review 9.  Structural and functional imaging studies in chronic cannabis users: a systematic review of adolescent and adult findings.

Authors:  Albert Batalla; Sagnik Bhattacharyya; Murat Yücel; Paolo Fusar-Poli; Jose Alexandre Crippa; Santiago Nogué; Marta Torrens; Jesús Pujol; Magí Farré; Rocio Martin-Santos
Journal:  PLoS One       Date:  2013-02-04       Impact factor: 3.240

10.  Delta-9-tetrahydrocannabinol, neural oscillations above 20 Hz and induced acute psychosis.

Authors:  Judith F Nottage; James Stone; Robin M Murray; Alex Sumich; Elvira Bramon-Bosch; Dominic Ffytche; Paul D Morrison
Journal:  Psychopharmacology (Berl)       Date:  2014-07-20       Impact factor: 4.530

View more
  2 in total

1.  Δ9-THC reduces reward-related brain activity in healthy adults.

Authors:  Conor H Murray; James E Glazer; Royce Lee; Robin Nusslock; Harriet de Wit
Journal:  Psychopharmacology (Berl)       Date:  2022-05-25       Impact factor: 4.415

2.  Marijuana use in children: An update focusing on pediatric tetrahydrocannabinol and cannabidiol use.

Authors:  Michael J Stoner; Ann Dietrich; Samuel Hiu-Fung Lam; Jessica J Wall; Carmen Sulton; Emily Rose
Journal:  J Am Coll Emerg Physicians Open       Date:  2022-07-05
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.